Concentrix (CNXC) officer sells 500 shares at $42.53 via 10b5-1
Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.
Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 500 | $42.53 | $21K |
Footnotes (1)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan by the reporting person on January 28, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Concentrix (CNXC) disclose in this Form 4?
Was the CNXC insider sale under a 10b5-1 plan?
What is the insider’s role at Concentrix (CNXC)?
What is the transaction date in the CNXC Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.